ArticleDiabetes & vascular disease research
Benefits of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide-1 receptor agonists in older patients with type 2 diabetes.
Ibrahim Mortada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.